摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-9,10-secocholesta-5,7,10(19)-trien-11α,25-diol | 159352-64-4

中文名称
——
中文别名
——
英文名称
(5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-9,10-secocholesta-5,7,10(19)-trien-11α,25-diol
英文别名
(3R,3aR,5S,7E,7aS)-7-[(2Z)-2-[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylidenecyclohexylidene]ethylidene]-3-[(2R)-6-hydroxy-6-methylheptan-2-yl]-3a-methyl-2,3,4,5,6,7a-hexahydro-1H-inden-5-ol
(5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-9,10-secocholesta-5,7,10(19)-trien-11α,25-diol化学式
CAS
159352-64-4
化学式
C39H72O4Si2
mdl
——
分子量
661.169
InChiKey
RATQXHSDQOYSJX-AGAUCTRDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.73
  • 重原子数:
    45
  • 可旋转键数:
    12
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-9,10-secocholesta-5,7,10(19)-trien-11α,25-diol吡啶四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 79.0h, 生成 (5Z,7E)-(1S,3R)-3-<<1,3,25-trihydroxy-9,10-secocholesta-5,7,10(19)-trien-11α-yl>oxycarbonyl>propanoic acid
    参考文献:
    名称:
    Syntheses of 11α-(3-carboxypropanoyloxy)-1α,25-dihydroxyvitamin D3and 11α(4-carboxybutanoyloxy)-1α,25-dihydroxyvitarnin D3: novel haptenic derivatives for production of highly specific antibodies to 1α,25-dihydroxyvitamin D31
    摘要:
    The measurement of serum/plasma levels of 1 alpha,25-dihydroxyvitamin D-3 1a is important for the diagnosis of diseases influencing vitamin D metabolism. To obtain antibodies to the metabolite 1a which are highly specific and useful for development of immunoassays, two novel haptenic derivatives. 11 alpha-(3-carboxypropanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2a and 11 alpha-(4-carboxybutanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2b were synthesized each in 19 steps from a suitably protected derivative (3) of 11 alpha,25-dihydroxycholesterol.
    DOI:
    10.1039/p19940001809
  • 作为产物:
    描述:
    (5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-25-hydroxy-9,10-secocholesta-5,7,10(19)-trien-11α-yl acetate 在 氢氧化钾 作用下, 以 甲醇 为溶剂, 生成 (5Z,7E)-(1S,3R)-1,3-bis(tert-butyldimethylsiloxy)-9,10-secocholesta-5,7,10(19)-trien-11α,25-diol
    参考文献:
    名称:
    利用在11个alpha位置具有化学桥的新型半抗原衍生物,生产针对1 alpha,25-dihydroxyvitamin D3的高特异性抗体。
    摘要:
    已经报道了利用新型半抗原衍生物2产生针对1α,25-二羟基维生素D3 1a的高特异性抗体,该新半抗原衍生物由11个α,25-二羟基胆固醇经21个步骤合成。还描述了获得的抗体的特性。
    DOI:
    10.1248/cpb.41.1321
点击查看最新优质反应信息

文献信息

  • Production of Highly Specific Antibodies to 1.ALPHA.,25-Dihydroxyvitamin D3 Utilizing a Novel Haptenic Derivative Having a Chemical Bridge at 11.ALPHA.-Position.
    作者:Norihiro KOBAYASHI、Junichi KITAHORI、Hidetoshi MANO、Kazutake SHIMADA
    DOI:10.1248/cpb.41.1321
    日期:——
    The production of highly specific antibodies to 1 alpha,25-dihydroxyvitamin D3 1a utilizing a novel haptenic derivative 2, which was synthesized from 11 alpha,25-dihydroxycholesterol via 21 steps, has been reported. The properties of the obtained antibodies are also described.
    已经报道了利用新型半抗原衍生物2产生针对1α,25-二羟基维生素D3 1a的高特异性抗体,该新半抗原衍生物由11个α,25-二羟基胆固醇经21个步骤合成。还描述了获得的抗体的特性。
  • Syntheses of 11α-(3-carboxypropanoyloxy)-1α,25-dihydroxyvitamin D<sub>3</sub>and 11α(4-carboxybutanoyloxy)-1α,25-dihydroxyvitarnin D<sub>3</sub>: novel haptenic derivatives for production of highly specific antibodies to 1α,25-dihydroxyvitamin D<sub>3</sub><sup>1</sup>
    作者:Norihiro Kobayashi、Junichi Kitahori、Hidetoshi Mano、Kazutake Shimada
    DOI:10.1039/p19940001809
    日期:——
    The measurement of serum/plasma levels of 1 alpha,25-dihydroxyvitamin D-3 1a is important for the diagnosis of diseases influencing vitamin D metabolism. To obtain antibodies to the metabolite 1a which are highly specific and useful for development of immunoassays, two novel haptenic derivatives. 11 alpha-(3-carboxypropanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2a and 11 alpha-(4-carboxybutanoyloxy)-1 alpha,25-dihydroxyvitamin D-3 2b were synthesized each in 19 steps from a suitably protected derivative (3) of 11 alpha,25-dihydroxycholesterol.
查看更多